What was known before {#section16-2054358117692560}
=====================

Positive fluid balance is common in critically ill children and independently associated with worse outcomes.

What this adds {#section17-2054358117692560}
==============

This systematic review will comprehensively appraise and summarize the evidence evaluating the association between fluid balance and outcomes in critically ill children

Background {#section18-2054358117692560}
==========

Fluid therapy is the cornerstone of resuscitation in critically ill children. Reestablishment of adequate intravascular volume using early aggressive fluid administration is lifesaving.^[@bibr1-2054358117692560][@bibr2-2054358117692560]-[@bibr3-2054358117692560]^ Moreover, beyond fluid therapy directed at resuscitation, critically ill children often receive variable amounts of obligatory fluid intake (ie, medications, nutrition, transfusions).^[@bibr4-2054358117692560],[@bibr5-2054358117692560]^ This cumulative fluid delivery often exceeds net fluid loss, leading to a positive fluid balance. Growing body of circumstantial evidence suggests that the accumulation of fluid beyond the initial resuscitation phase may exert an incremental risk for major morbidity and mortality.^[@bibr4-2054358117692560][@bibr5-2054358117692560][@bibr6-2054358117692560][@bibr7-2054358117692560][@bibr8-2054358117692560][@bibr9-2054358117692560]-[@bibr10-2054358117692560]^ These observations highlight the importance of monitoring fluid status and evaluating for the degree of fluid accumulation. As a consequence, fluid balance is routinely measured in critically ill children using several methods such as recorded daily intake-output and serial body weight measurements. However, the precision of such methods in accurately reflecting intravascular volume status or reliably correlating with the clinical manifestations of fluid accumulation is questionable.^[@bibr11-2054358117692560][@bibr12-2054358117692560][@bibr13-2054358117692560]-[@bibr14-2054358117692560]^

The concept of "fluid overload" has been described in the literature using various definitions. Although some of the proposed definitions have been shown to correlate with outcomes, it is unclear how generalizable some of these findings are in light of study size and design limitations. The majority of prior studies were small, single center, and often evaluated fluid overload in specific clinical settings (such as bone marrow transplant or post--cardiac surgery patients). Significant discrepancy in fluid overload estimation can occur, depending on the definition used.^[@bibr15-2054358117692560]^ Furthermore, none of these definitions integrated the rate of fluid accumulation and the time frame in which it occurred in relation to different phases of critical illness. There is no broad consensus on how to precisely and reliably define the terms fluid accumulation and fluid overload, and we believe this may be hindering progress in the field.

In view of these limitations, we aim to conduct a systematic review and meta-analysis to appraise and synthesize the evidence describing the methods to measure fluid balance, define fluid overload, and evaluate the association between the various fluid-related metrics and outcomes in critically ill children. Synthesis of the available evidence is an important step in providing a foundation that will harmonize the various definitions of fluid metrics and help develop future interventional strategies to prevent or mitigate avoidable fluid accumulation and overload.

Objectives {#section19-2054358117692560}
==========

-   Describe the methods used to measure fluid balance in critically ill children

-   Describe the definitions for fluid balance, fluid accumulation, and fluid overload in critically ill children

-   Evaluate the association between fluid balance and mortality in critically ill children

-   Evaluate the association between fluid balance and organ dysfunction and resource utilization in critically ill children.

Methods {#section20-2054358117692560}
=======

Study Design {#section21-2054358117692560}
------------

We will perform a systematic review and meta-analysis focused on critically ill children exploring the methods used to assess fluid balance, define fluid overload, and evaluate the association between fluid balance and outcomes. Our review will follow the format recommended by the Cochrane and Center for Reviews and Dissemination, and described according to the PRISMA-P guideline^[@bibr16-2054358117692560],[@bibr17-2054358117692560]^ (Additional file 1).

Study Registration {#section22-2054358117692560}
------------------

This systematic review has been registered with PROSPERO (CRD42016036209) in March 2016.

Criteria for Considering Studies for This Review {#section23-2054358117692560}
------------------------------------------------

### Inclusion criteria {#section24-2054358117692560}

All included studies will fulfill each of these criteria:

1.  Population: studies enrolling patients below 25 years of age, admitted to a pediatric critical care setting.

2.  Design: studies reporting original data incorporating interventional (randomized controlled trials or quasi-randomized controlled trials), cohort or case-control studies.

3.  Exposure: studies describe a measure of fluid balance, fluid accumulation, and/or fluid overload.

4.  Outcome: studies describe at least one of the following outcomes of interest:

#### Primary outcome {#section25-2054358117692560}

-   28-day mortality

#### Secondary outcomes {#section26-2054358117692560}

-   Severity of illness scores (eg, Pediatric Risk of Mortality \[PRISM\])

-   Organ failure scores (eg, Pediatric Logistic Organ Dysfunction \[PELOD\])

-   Specific organ system dysfunction: PaO~2~/FiO~2~ ratio and/or oxygenation indexReceipt and duration of mechanical ventilationReceipt and duration of renal replacement therapy

-   Receipt and duration of extracorporeal life support (ECLS)

-   Duration of pediatric intensive care unit (PICU) and hospital length of stay

### Exclusion criteria {#section27-2054358117692560}

1.  Adult studies (age ≥25 years)

2.  Neonatal studies inclusive of premature infants or infants younger than 4 weeks of age

3.  Case reports, case series, or observational studies that do not include a control/comparator

4.  Studies conducted in noncritical care settings

Search Strategy for Identification of Studies {#section28-2054358117692560}
=============================================

The search strategy was developed in consultation with an experienced research librarian and independently peer-reviewed by a second librarian.^[@bibr18-2054358117692560]^ The search will be inclusive of all publications from database inception to present. We will search Ovid MEDLINE In-Process & Other Non-indexed Citations and Ovid MEDLINE, Ovid EMBASE, Cochrane Library via Wiley, and ProQuest Dissertations and Theses Global. In addition, [www.clinicaltrials.gov](http://www.clinicaltrials.gov) and World Health Organization International Clinical Trials Registry Platform (WHO ICTRP) will be searched for ongoing and completed clinical trials. We will perform a search of selected conference proceedings held within the last 3 years for the Society of Critical Care Medicine (SCCM), Canadian Critical Care Society, the European Society of Intensive Care Medicine (ESICM), the International Symposium on Intensive Care and Emergency Medicine (ISICEM), the World Federation of Pediatric Intensive and Critical Care Societies, American Society of Nephrology (ASN), International Society of Nephrology (ISN), International Symposium on AKI in Children, and International Conference on Paediatric Continuous Renal Replacement Therapy (pCRRT). There will be no language restriction. Authors will be contacted by email to request additional data not described in a primary publication or data from unpublished studies if applicable. Our search strategy will use a combination of subject headings and text words for concepts related to children, critical illness, and fluid balance (Additional file 2). Finally, we will manually search for relevant studies using reference lists of retrieved citations and prior reviews of similar topics. Search results will be organized using EndNote X7 citation management software (Thomson Reuters, Philadelphia, Pennsylvania).

Data Extraction and Analysis {#section29-2054358117692560}
============================

All identified titles and abstracts of studies examining the association between fluid balance and outcomes in pediatric population will be initially assessed independently by 2 reviewers for potential relevance. Selected studies will be retrieved and then be subjected to a second phase of screening for eligibility, as determined by the eligibility criteria listed above. Reason(s) for ineligibility will be documented for all studies excluded in the second phase of screening. Disagreements will be resolved through discussion or by a third reviewer if necessary.

A standardized data extraction form (Additional file 3) will be piloted and then used to extract data from the reports of all included studies in duplicate, and independently by 2 reviewers. Discrepancies in extracted data will be resolved by consensus, and if consensus cannot be reached, decisions will be left to the senior author (S.M.B).

Abstracted data from each study will include the details on the following:

-   Study design, methodology, analysis, funding source, registration, and publication details.

-   Aggregate participant demographic characteristics (eg, age, sex, and race).

-   Aggregate participant clinical characteristics (eg, comorbid diseases, admission diagnostic category, and surgical status).

-   Operational definitions for fluid balance, accumulation, and fluid overload, data on daily and cumulative fluid balance, and proportion and timing of occurrence of fluid accumulation and fluid overload.

-   All primary and secondary outcomes reported, with their effect size and confidence intervals.

-   Study quality features (see below).

Assessment of Methodological Quality and Risk of Bias {#section30-2054358117692560}
=====================================================

Studies selected for retrieval will be assessed by 2 independent reviewers for methodological quality and risk of bias. Any disagreements that arise between the reviewers will be resolved through discussion, or with a third reviewer (S.M.B.). The Newcastle-Ottawa Scale (NOS) will be used to assess the methodological quality of the included study.

Data Synthesis/Analysis Plan {#section31-2054358117692560}
============================

The results of our search will be reported in a PRISMA flowchart. We will present tables outlining (1) study characteristics, (2) risk of bias for each study, and (3) study results and their effect measures. Quantitative studies will, where possible, be pooled in statistical meta-analysis. We will use random effects model to pool effect sizes for each outcome; study weights will be measured using the inverse variance method. Dichotomous outcomes will be reported, where possible, as pooled odd ratios and 95% confidence intervals based on the random effects model. Continuous outcomes will be reported using calculated weighted mean differences with their 95% confidence intervals. We will use the DerSimonian and Laird method to compute between-studies variance.^[@bibr19-2054358117692560]^ Results will be presented in forest plot using Review Manager (RevMan 5.3) software. We will contact authors for missing data, and if not possible, the potential impact of missing data on the results will be reported in the "Discussion" section. If statistical pooling is not possible, or if there are data from only 1 study for an outcome, the findings will be presented in narrative form. A priori, we have not defined a degree of heterogeneity that would preclude meta-analytic pooling.

Assessment of Heterogeneity {#section32-2054358117692560}
===========================

Clinical heterogeneity will be assessed by comparing the populations, exposures, and outcome measurements in all included studies. We will address clinical heterogeneity using subgroup and sensitivity analyses. Heterogeneity will be assessed statistically using *I*^2^ statistics and categorized as \<25%, 25% to 50%, 50% to 75%, and \>75%.^[@bibr20-2054358117692560]^ Heterogeneity will also be evaluated using forest plots and sensitivity analyses based on the different study designs included in the review.

Assessment of Reporting Bias {#section33-2054358117692560}
============================

We will assess potential reporting bias using a funnel plot if a sufficient number of studies are identified (\>10 studies). Visual assessment and variance-stabilizing regression method will be used to test funnel plot asymmetry.

Subgroup Analysis {#section34-2054358117692560}
=================

Depending on the number of studies included in the final analysis, the following subgroup analyses will be performed:

1.  Infants (\<1 year of age) and older children.

2.  Children with primary cardiac and noncardiac diagnosis.

3.  Sepsis and nonsepsis diagnosis.

4.  Surgical and nonsurgical admissions.

Discussion {#section35-2054358117692560}
==========

While timely fluid administration can be lifesaving, it has been suggested that the accumulation of fluid after initial resuscitation and hemodynamic stabilization can contribute to potentially avoidable adverse consequences and less favorable outcomes. Available studies of fluid balance in pediatric critical illness show that positive fluid balance potentially exerts an independent increased risk for mortality and adverse events, including worsening pulmonary and kidney function, longer duration of mechanical ventilation, and longer duration of PICU stay. While provocative, current evidence is largely derived from small, single-center, retrospective cohort studies, where variable definitions for fluid overload have been applied. The prevention or attenuation of fluid accumulation could improve patient-centered outcomes and health resource utilization.

Expected Limitations {#section36-2054358117692560}
====================

The review may be limited by the quality of the included studies and a lack of pediatric interventional studies focused on this subject. Differences in definitions of fluid balance and fluid overload between studies may restrict the ability to synthesize the study findings. It also may be limited because of significant clinical or statistical heterogeneity between studies. The absence of specific fluid metrics data in some studies may limit our ability to include them in the meta-analysis. The number of studies included in the final analysis, their sample size, and access to individual data will determine the ability to conduct the proposed subgroup analyses.

Conclusion {#section37-2054358117692560}
==========

We will perform a systematic review and evidence synthesis of fluid balance, accumulation, and overload among critically ill children and its association with patient-centered and health services outcomes. We expect our review will describe the broad impact of fluid accumulation and provide a foundation that will harmonize the various definitions for fluid metrics. This will help the development of future interventional strategies to prevent or mitigate avoidable fluid accumulation with the goal of improving outcomes for critically ill children at high risk of adverse events.
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